PV-10 Mechanism of Action Data to Be Presented at the Society of Surgical ... - MarketWatch (press release)

PV-10 Mechanism of Action Data to Be Presented at the Society of Surgical ... MarketWatch (press release) Its medicine drug PH-10 also targets abnormal or diseased cells, with the current focussing on psoriasis and atopic dermatitis. Provectus has lately completed Phase 2 trials of PV-10 as type A therapy for metastatic melanoma, and of PH-10 As a topical ... and more » Link To Article